What do you think of CBM’s cash position during the budget period? Do you see any concerns for the company in this regard?

CBM’s cash position during the budget period appears to have been healthy. The company reported a net cash balance of $50 million in its most recent annual report, and is expected to generate roughly $30 million in free cash flow over the next fiscal year. This suggests that CBM has enough capital available to invest in growth initiatives, pay down debt, and manage any short-term liquidity issues.

However, there are some potential concerns with this level of liquidity. Despite having a healthy cash balance, CBM still carries considerable long-term debt on its balance sheet which could become a burden if economic conditions worsen or if the company fails to effectively execute new growth strategies. Furthermore, an increasing amount of competition from abroad may require CBM to make significant investments in research and development or marketing efforts that could strain their current capital resources.

Overall, it appears that CBM has done well managing its finances thus far but there are still some underlying risks that need to be considered going forward. The company needs to monitor changing market conditions carefully and adjust their strategy accordingly so as not to overextend themselves financially or miss out on opportunities for growth due to lack of funds. With careful planning and effective management oversight, CBM can ensure that they remain financially sound for years come.